Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Helus Pharma has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Helus Pharma's investors include RA Capital Management, Janus Henderson Investors, Adage Capital Management, Point72, OrbiMed.
Helus Pharma is headquartered in Toronto, Canada.
Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.
Helus Pharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helus Pharma — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/helus-pharma. Accessed August 14, 2026.
VCBacked. (2026). Helus Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/helus-pharma
{{cite web |title=Helus Pharma — Funding & Investors |url=https://www.vcbacked.co/company/helus-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated